Advances in Rheumatic Fever Research and Treatment: 2012 Edition

Advances in Rheumatic Fever Research and Treatment: 2012 Edition
Author:
Publisher: ScholarlyEditions
Total Pages: 18
Release: 2012-12-26
Genre: Medical
ISBN: 1481638416

Advances in Rheumatic Fever Research and Treatment / 2012 Edition is a ScholarlyPaper™ that delivers timely, authoritative, and intensively focused information about Rheumatic Fever in a compact format. The editors have built Advances in Rheumatic Fever Research and Treatment / 2012 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Rheumatic Fever in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Advances in Rheumatic Fever Research and Treatment / 2012 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.

Acute Rheumatic Fever and Rheumatic Heart Disease

Acute Rheumatic Fever and Rheumatic Heart Disease
Author: Dr. Scott Dougherty
Publisher: Elsevier Health Sciences
Total Pages: 364
Release: 2020-02-22
Genre: Medical
ISBN: 0323754600

Acute Rheumatic Fever and Rheumatic Heart Disease is a concise, yet comprehensive, clinical resource highlighting must-know information on rheumatic heart disease and acute rheumatic fever from a global perspective. Covering the major issues dominating the field, this practical resource presents sufficient detail for a deep and thorough understanding of the latest treatment options, potential complications, and disease management strategies to improve patient outcomes. - Divided into four distinct sections for ease of navigation: Acute Rheumatic Fever, Rheumatic Heart Disease, Population-Based Strategies for Disease Control, and Acute and Emergency Presentations. - International editors and chapter authors ensure a truly global perspective. - Covers all clinical aspects, including epidemiology, pathophysiology, clinical features, diagnosis, management, and treatment. - Includes key topics on population-based measures for disease control for effective primary, secondary, and tertiary prevention. - Consolidates today's available information and guidance into a single, convenient resource.

Streptococcal Infections—Advances in Research and Treatment: 2012 Edition

Streptococcal Infections—Advances in Research and Treatment: 2012 Edition
Author:
Publisher: ScholarlyEditions
Total Pages: 82
Release: 2012-12-26
Genre: Medical
ISBN: 1481608207

Streptococcal Infections—Advances in Research and Treatment: 2012 Edition is a ScholarlyBrief™ that delivers timely, authoritative, comprehensive, and specialized information about Streptococcal Infections in a concise format. The editors have built Streptococcal Infections—Advances in Research and Treatment: 2012 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Streptococcal Infections in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Streptococcal Infections—Advances in Research and Treatment: 2012 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.

Rheumatic Fever

Rheumatic Fever
Author: Angelo Taranta
Publisher: Springer Science & Business Media
Total Pages: 95
Release: 2012-12-06
Genre: Medical
ISBN: 9401571716

It has become commonplace to say that the decline of rheu matic fever in Europe and North America has little, if any thing, to do with medicine; but to conclude that efforts to control the disease are futile would be an error leading to what could be termed public health malpractice. The need for adequate treatment of patients suffering from acute rheu matic fever or chronic rheumatic valvular heart disease is obvious; but control also means prevention, and here, too, the need is obvious, if only to lighten the burden on health care, due especially to the treatment of patients with advanced forms of the disease. The feasibility of and justification for rheumatic fever control programmes in developing countries has been often questioned. A co-operative study co-ordinated by the World Health Organization has now demonstrated that systematic prevention of rheumatic fever recurrences not only benefits the patients concerned but also has economic advantages. Primary prevention by systematic penicillin treatment of all streptococcal throat infections is at present beyond the reach of many health care systems, and anti-streptococcal vac cination is still in the research phase. The mainstay of the combat against rheumatic heart disease thus remains 7 RHEUMATIC FEVER secondary prevention - the long-term monthly administ ration of penicillin injections to identified patients. This requires, among other things, that penicillin be available.

The Management of Acute Respiratory Infections in Children

The Management of Acute Respiratory Infections in Children
Author: World Health Organization
Publisher: World Health Organization
Total Pages: 88
Release: 1995
Genre: Medical
ISBN: 9241544775

A step-by-step guide to the correct management of respiratory infections in infants and young children. Addressed to staff in first-level health facilities, the book explains how to assess a child, recognize symptoms, classify the illness, and provide appropriate treatment, whether involving immediate referral to hospital, treatment with antibiotics at home, or simple home care. Throughout, a special effort is made to help staff distinguish the few, very sick children from the many others whose infections can be safely treated at home. The manual also aims to help prevent deaths from pneumonia and other severe illnesses by offering abundant advice on the recognition and urgent management of danger signs. The manual has two parts, each based on the use of a quick-reference case management chart, reproduced in a foldout version. Part one covers the management of pneumonia, wheezing, coughs and colds. Advice on how to collect essential information about the signs of respiratory problems is followed by a description of the steps involved in classifying the illness, determining the degree of severity, and identifying the appropriate treatment. Part one concludes with detailed treatment instructions, including how to give an antibiotic and treat fever and wheezing. Part two explains how to assess, classify, and treat the child with an ear problem or sore throat. Treatment instructions include advice on how to dry the ear by wicking, give an antibiotic, and manage streptococcal sore throat. Further practical information is provided in a series of annexes, which explain how to refer a child to hospital, what to do when referral is not feasible, how to use a rapid-acting bronchodilator, and how to determine whether complaints and symptoms are due to measles, pertussis, or diphtheria.

Disease Control Priorities, Third Edition (Volume 5)

Disease Control Priorities, Third Edition (Volume 5)
Author: Dorairaj Prabhakaran
Publisher: World Bank Publications
Total Pages: 948
Release: 2017-11-17
Genre: Medical
ISBN: 1464805202

Cardiovascular, respiratory, and related conditions cause more than 40 percent of all deaths globally, and their substantial burden is rising, particularly in low- and middle-income countries (LMICs). Their burden extends well beyond health effects to include significant economic and societal consequences. Most of these conditions are related, share risk factors, and have common control measures at the clinical, population, and policy levels. Lives can be extended and improved when these diseases are prevented, detected, and managed. This volume summarizes current knowledge and presents evidence-based interventions that are effective, cost-effective, and scalable in LMICs.

Cardiovascular Diseases—Advances in Research and Treatment: 2012 Edition

Cardiovascular Diseases—Advances in Research and Treatment: 2012 Edition
Author:
Publisher: ScholarlyEditions
Total Pages: 721
Release: 2012-12-26
Genre: Medical
ISBN: 1464991766

Cardiovascular Diseases—Advances in Research and Treatment: 2012 Edition is a ScholarlyEditions™ eBook that delivers timely, authoritative, and comprehensive information about Cardiovascular Diseases. The editors have built Cardiovascular Diseases—Advances in Research and Treatment: 2012 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Cardiovascular Diseases in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Cardiovascular Diseases—Advances in Research and Treatment: 2012 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.

Rheumatic Fever and Rheumatic Heart Disease

Rheumatic Fever and Rheumatic Heart Disease
Author: World Health Organization
Publisher: World Health Organization
Total Pages: 130
Release: 2004-02-04
Genre: Medical
ISBN: 9241209232

Rheumatic heart disease presents a major public health challenge (particularly for children) and major determinants are poverty, malnutrition, overcrowding, poor housing and a shortage of health-care resources. Although cost effective prevention and control strategies are available, they remain underused in most developing countries. This publication contains the report of a WHO expert consultation, held in Geneva in October 2001, which reviewed the current scientific knowledge of rheumatic fever and rheumatic heart disease, as well as the medical and public health related practices. It suggests practical recommendations for an evidence-based approach to the prevention and management of the disease and for cost-effective programmes for their control.

Polymyalgia Rheumatica and Giant Cell Arteritis

Polymyalgia Rheumatica and Giant Cell Arteritis
Author: Jozef Rovensky
Publisher: Springer Science & Business Media
Total Pages: 93
Release: 2010-05-06
Genre: Medical
ISBN: 3211993592

In the present monograph, we offer current insights into polymyalgia rheumatica and giant cell arthritis. Both diseases are typical for advanced age, and their incidences increase with aging. Both diseases are a center point of interest not only for rheu- tologists, gerontologists, ophthalmologists or neurologists, but also for general prac- tioners. Early diagnosis and rapid treatment, mainly with glucocorticoids can save one of the most precious senses-vision. Damage to other organs (heart, aorta, co- nary arteries, liver, lungs, kidneys), which are supplied by the arteries affected by ischemic syndrome in the setting of giant cell arthritis, has serious consequences as well. Late diagnosis of giant cell arthritis can have fatal consequences for affected patients. It is a matter of fact that the human population is aging. Therefore, more attention has to be paid not only to diagnosis, clinical course and treatment of rheumatic d- eases in elderly, but also to their genetic, immunologic, endocrinologic, chronobiologic mechanisms, and state-of-the-art diagnostic modalities. I am convinced that the int- disciplinary research of the diseases will allow us to diagnose and treat the rheumatic diseases even faster and more effectively in the future.